Category: Peptide Q&A
-
Has SLU-PP-332 demonstrated protective effects against age-related hearing loss or retinal degeneration in animal models, and what pathways are involved?
Has SLU-PP-332 demonstrated protective effects against age-related hearing loss or retinal degeneration in animal models, and what pathways are involved
-
How does SLU-PP-332 compare to rapamycin in extending healthspan in C. elegans and mouse models, particularly in terms of mitochondrial function and proteostasis?
How does SLU-PP-332 compare to rapamycin in extending healthspan in C. elegans and mouse models, particularly in terms of mitochondrial function and pro
-
Does SLU-PP-332 cross the blood-brain barrier effectively, and what pharmacokinetic studies support its CNS bioavailability in non-human primates?
Does SLU-PP-332 cross the blood-brain barrier effectively, and what pharmacokinetic studies support its CNS bioavailability in non-human primates?
-
What impact does SLU-PP-332 have on neuroinflammation, particularly microglial activation and IL-1β/ TNF-α release, in the context of chronic neurodegeneration?
What impact does SLU-PP-332 have on neuroinflammation, particularly microglial activation and IL-1β/ TNF-α release, in the context of chronic neurodegen
-
What are the challenges in scaling up the synthesis of SLU-PP-332 for clinical use, and how might this affect cost and accessibility?
What are the challenges in scaling up the synthesis of SLU-PP-332 for clinical use, and how might this affect cost and accessibility?
-
How does SLU-PP-332 affect insulin sensitivity and glucose uptake in skeletal muscle and adipose tissue, and what genetic or proteomic evidence supports its role in enhancing metabolic flexibility?
How does SLU-PP-332 affect insulin sensitivity and glucose uptake in skeletal muscle and adipose tissue, and what genetic or proteomic evidence supports
-
How does SLU-PP-332 influence brown adipose tissue (BAT) thermogenesis and energy expenditure in cold-exposed mice?
How does SLU-PP-332 influence brown adipose tissue (BAT) thermogenesis and energy expenditure in cold-exposed mice?
-
Does SLU-PP-332 activate AMPK signaling pathways independently of changes in AMP:ATP ratio, and what evidence supports this in neuronal cells?
Does SLU-PP-332 activate AMPK signaling pathways independently of changes in AMP:ATP ratio, and what evidence supports this in neuronal cells?
-
What changes in hepatic lipid metabolism have been observed in high-fat-diet-fed rodents treated with SLU-PP-332, and how do these compare to those induced by metformin or GLP-1 agonists?
What changes in hepatic lipid metabolism have been observed in high-fat-diet-fed rodents treated with SLU-PP-332, and how do these compare to those indu
-
Is there evidence for a dose-dependent effect of SLU-PP-332 on mitochondrial biogenesis markers such as PGC-1α and NRF-1 in brain tissue?
Is there evidence for a dose-dependent effect of SLU-PP-332 on mitochondrial biogenesis markers such as PGC-1α and NRF-1 in brain tissue?